255 related articles for article (PubMed ID: 21280986)
1. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.
Kalogiannidis I; Agorastos T
J Obstet Gynaecol; 2011; 31(1):13-7. PubMed ID: 21280986
[TBL] [Abstract][Full Text] [Related]
2. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
[TBL] [Abstract][Full Text] [Related]
4. The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option.
Gadducci A; Spirito N; Baroni E; Tana R; Genazzani AR
Gynecol Endocrinol; 2009 Oct; 25(10):683-91. PubMed ID: 19562604
[TBL] [Abstract][Full Text] [Related]
5. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
Wang HY; Shen L; Sun Z
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
[TBL] [Abstract][Full Text] [Related]
6. [Fertility sparing management of endometrial adenocarcinoma and atypical hyperplasia: a literature review].
Koskas M; Yazbeck C; Walker F; Delorme P; Azria E; Luton D; Madelenat P
Bull Cancer; 2012 Jan; 99(1):51-60. PubMed ID: 22212645
[TBL] [Abstract][Full Text] [Related]
7. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Corrado G; Baiocco E; Carosi M; Vizza E
Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
[TBL] [Abstract][Full Text] [Related]
8. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
9. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment.
Benshushan A
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):132-7. PubMed ID: 15541846
[TBL] [Abstract][Full Text] [Related]
10. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
[TBL] [Abstract][Full Text] [Related]
11. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
[TBL] [Abstract][Full Text] [Related]
12. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer.
Gonthier C; Walker F; Luton D; Yazbeck C; Madelenat P; Koskas M
Gynecol Oncol; 2014 Apr; 133(1):33-7. PubMed ID: 24680589
[TBL] [Abstract][Full Text] [Related]
13. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.
Ricciardi E; Maniglio P; Frega A; Marci R; Caserta D; Moscarini M
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1934-7. PubMed ID: 23242719
[TBL] [Abstract][Full Text] [Related]
14. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
Arteaga Gómez AC; Castellanos Barroso G; Márquez Acosta G
Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
[TBL] [Abstract][Full Text] [Related]
15. [Conservative treatment of endometrial cancer and atypical hyperplasia].
Yazbeck C; Dhainaut C; Thoury A; Driguez P; Madelenat P
Gynecol Obstet Fertil; 2004 May; 32(5):433-41. PubMed ID: 15177216
[TBL] [Abstract][Full Text] [Related]
16. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
Eur J Cancer; 2013 Mar; 49(4):868-74. PubMed ID: 23072814
[TBL] [Abstract][Full Text] [Related]
17. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
18. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
[TBL] [Abstract][Full Text] [Related]
19. Sparing fertility in young patients with endometrial cancer.
Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
[TBL] [Abstract][Full Text] [Related]
20. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
